Description
Deepthy Varghese, MSN, FNP of Northside Hospital is joined by guests David B. De Lurgio, MD, FHRS, and Bradley Pitman, CCDS, PhD, BHSc, BSc, to discuss "Incidence and management of Atrioventricular conduction disorders in a new-onset left bundle branch block after TAVI: A prospective multi center study” published in Heart Rhythm Journal in May 2023.
Learning Objectives
- Risk stratification of patients with a new left bundle branch block following TAVI procedure.
- Cost effectiveness of empirical pacing therapy in this high risk group of patients.
Article Authors and Podcast Contributors
Article Authors
Grégoire Massoullié, MDm, Sylvain Ploux, MD, PhD, Géraud Souteyrand, MD, Pierre Mondoly, MD, PhD, Bruno Pereira, PhD, Nicolas Amabile, MD, PhD, Frédéric Jean, MD, Didier Irles, MD, Jacques Mansourati, MD, PhD, Nicolas Combaret, MD, PhD, Alexis Mechulan, MD, PhD, Marc Badoz, MD, Antoine Da Costa, MD, PhD, Pascal Defaye, MD, PhD, Pascal Motreff, MD, PhD, Guillaume Clerfond, MD, Pierre Bordachar, MD, PhD, and Romain Eschalier, MD, PhD
Podcast Contributors
Deepthy Varghese, MSN, ACNP, FNP, of Northside Hospital
David B. De Lurgio, MD, FHRS, of Emory St. Joseph Hospital
Bradley Pitman, CCDS, PhD, BHSc, BSc, of University of Adelaide and Royal Adelaide Hospital
Disclosure Policy
ACE Disclosure Policy
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.
Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.
ACCME Definition:
*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
All relevant financial relationships have been mitigated.Host Disclosure(s):
D. Varghese: No relevant financial relationships with ineligible companies to disclose.
Contributor Disclosure(s):
D. De Lurgio: Honoraria/Speaking/Consulting Fee: Boston Scientific, Medtronic, AtriCure, Inc.B. Pitman: Honoraria/Speaking/Consulting Fee: Abbott, MicroPort Scientific, CathRx
Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn: No relevant financial relationships with ineligible companies to disclose.
S. Sailor: No relevant financial relationships with ineligible companies to disclose.